Multilevel and continuous pleural fluid pH likelihood ratios for evaluating malignant pleural effusions

被引:23
作者
Heffner, JE
Heffner, JN
Brown, LK
机构
[1] Med Univ S Carolina, Div Pulm & Crit Care Med, Charleston, SC 29425 USA
[2] Univ Texas, Sch Law, Austin, TX 78712 USA
[3] Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA
[4] Lovelace Hlth Syst, Albuquerque, NM USA
关键词
diagnostic testing; malignant; pH; pleura; pleural effusions;
D O I
10.1378/chest.123.6.1887
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objective: Expert consensus recommends testing pleural fluid for pH to assist the selection of patients with malignant pleural effusions for pleurodesis. Although published studies report an association between pleural fluid pH and patient outcomes after pleurodesis, clinicians have no definitive information on how to use pH to select patients for pleurodesis. Thus, we quantitatively assessed different methods for deriving likelihood ratios from pleural fluid pH and evaluated the potential role of pH in selecting patients for pleurodesis. Data sources: MEDLINE, systematic reviews, article reference lists, and contact with primary authors. Study selection: Studies that assessed the impact of pleural fluid pH on survival and pleurodesis failure rates among patients with malignant pleural effusions. Data extraction: Primary authors provided their data in electronic spreadsheets. Data synthesis: Retrieved data sets included survival and pleurodesis failure rates for 417 patients and 433 patients, respectively. Binary, multilevel, and continuous likelihood ratios were calculated to estimate the likelihood of death within 3 months of pleurodesis or pleurodesis failure rates. Values for the likelihood ratios were compared for each of the three strategies, and relative clinical and statistical significance were assessed. Pleural fluid pH had marginal performance for identifying patients with < 3-month anticipated survival; binary likelihood ratios provided as much information as the multilevel and continuous strategies. Likelihood ratios for identifying patients likely to fail pleurodesis were clinically useful. Continuous likelihood ratios provided statistically more information as compared with the multilevel and binary strategies. Conclusions: Pleural fluid pH has marginal value for estimating death within 3 months of pleurodesis, and binary likelihood ratios (cut point less than or equal to 7.20) perform as well as the other strategies assessed. Pleural fluid pH pro-Odes more useful information for estimating the likelihood of pleurodesis failure for which continuous likelihood ratios provide the most information as compared with binary or multilevel likelihood ratios.
引用
收藏
页码:1887 / 1894
页数:8
相关论文
共 24 条
[1]   Thoracoscopic talc poudrage in malignant pleural effusions [J].
Aelony, Y ;
King, RR ;
Boutin, C .
CHEST, 1998, 113 (04) :1007-1012
[2]   Management of malignant pleural effusions [J].
Antony, VB ;
Loddenkemper, R ;
Astoul, P ;
Boutin, C ;
Goldstraw, P ;
Hott, J ;
Panadero, FR ;
Sahn, SA .
EUROPEAN RESPIRATORY JOURNAL, 2001, 18 (02) :402-419
[3]   CORYNEBACTERIUM-PARVUM PLEURODESIS [J].
FORESTI, V ;
VILLA, A .
CHEST, 1995, 107 (01) :291-292
[4]  
FORESTI V, 1995, RESPIRATION, V62, P21
[5]  
FORESTI V, 1990, ONCOLOGY, V47, P62
[6]  
GOOD JT, 1985, AM REV RESPIR DIS, V131, P737
[7]   PLEURAL FLUID ANALYSIS IN MALIGNANT MESOTHELIOMA - PROGNOSTIC IMPLICATIONS [J].
GOTTEHRER, A ;
TARYLE, DA ;
REED, CE ;
SAHN, SA .
CHEST, 1991, 100 (04) :1003-1006
[8]   Pleural fluid on as a predictor of pleurodesis failure - Analysis of primary data [J].
Heffner, JE ;
Nietert, PJ ;
Barbieri, C .
CHEST, 2000, 117 (01) :87-95
[9]   Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions [J].
Heffner, JE ;
Nietert, PJ ;
Barbieri, C .
CHEST, 2000, 117 (01) :79-86
[10]   USERS GUIDES TO THE MEDICAL LITERATURE .3. HOW TO USE AN ARTICLE ABOUT A DIAGNOSTIC-TEST .B. WHAT ARE THE RESULTS AND WILL THEY HELP ME IN CARING FOR MY PATIENTS [J].
JAESCHKE, R ;
GUYATT, GH ;
SACKETT, DL ;
GUYATT, G ;
BASS, E ;
BRILLEDWARDS, P ;
BROWMAN, G ;
COOK, D ;
FARKOUH, M ;
GERSTEIN, H ;
HAYNES, B ;
HAYWARD, R ;
HOLBROOK, A ;
JUNIPER, E ;
LEE, H ;
LEVINE, M ;
MOYER, V ;
NISHIKAWA, J ;
OXMAN, A ;
PATEL, A ;
PHILBRICK, J ;
RICHARDSON, WS ;
SAUVE, S ;
SACKETT, D ;
SINCLAIR, J ;
TROUT, KS ;
TUGWELL, P ;
TUNIS, S ;
WALTER, S ;
WILSON, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (09) :703-707